Skip to main content
. 2022 May 6;145(8):2671–2676. doi: 10.1093/brain/awac167

Table 1.

Numbers of patients with ATXN2 repeats in each diagnosis group

Longest repeat ALS ALSFTD Control FTD LBD
≤22 1767 45 2400 1230 2039
23 265 19 367 179 400
24 19 0 22 14 23
25 4 0 14 3 7
26 6 0 5 3 6
27 61 2 70 33 92
28 4 0 8 1 7
29 11 0 16 4 18
30 5 0 11 5 10
31 17 0 4 6 5
32 12 4 2 4 0
33 5 0 1 3 1
≥34 5 1 1 0 2
Totals 2181 71 2921 1485 2610